# OneBlood, Inc. – FDA Inspection, Feb 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/d4274806-8b3e-49c5-b97b-36dcc2829714
Source feed: FDA_Inspections

> FDA inspection 1081205 of OneBlood, Inc., February 26, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 630. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1081205
- Company Name: OneBlood, Inc.
- Inspection Date: 2019-02-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1250131 - 2024-09-24
- [FDA Inspection 1162423 - 2022-02-09](https://www.keypedia.com/records/fda_inspections/oneblood-inc/7257e527-59f0-46f9-943f-0866b45088a4)
- FDA Inspection 997062 - 2016-12-14
- FDA Inspection 913508 - 2015-02-11
- FDA Inspection 827219 - 2013-04-09

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/lura-d-kelly/f2f257a7-5988-48c1-86e1-a94c5ae97e7d)

Company: https://www.keypedia.com/companies/oneblood-inc/65af44b6-efd2-452e-bc8f-36508a8f1510

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
